Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global footprint and strong clinical differentiation. Supported by favorable ...

Teleflex, based in Wayne, plans on divesting three of its business divisions through two separate deals valued at a combined $2.03 billion, writes John George for the Philadelphia Business Journal.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Founded in 1943, the company has ...

(RTTNews) - Teleflex Inc. (TFX), a global provider of medical technologies, has entered into definitive agreements to divest its Acute Care, Interventional Urology, and OEM businesses for a combined ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

Teleflex Inc. announced that it has entered into definitive agreements to sell its OEM business as well as its acute care and interventional urology divisions to two different buyers. Intersurgical ...

Both transactions are expected to close by H2 2026. Image credit: Michael Vi via Shutterstock.com. Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) ...

Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.” Teleflex outlined plans to offload its ...

Teleflex announced agreements to sell its Acute Care, Interventional Urology, and OEM businesses for a total of $2.03 billion in cash. The Acute Care and Interventional Urology businesses will be sold ...